# MESALAMINE
> **ANDA208953** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2020-02-12
## Drug
- **FDA Application Number:** ANDA208953
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MESALAMINE
- **Generic name:** MESALAMINE
- **Active ingredients:** MESALAMINE
- **Dosage form:** SUPPOSITORY
- **Route:** RECTAL
- **Marketing status:** Prescription
- **Sponsor:** ZYDUS PHARMS
- **Manufacturer:** Northstar Rx LLC.
- **First approval:** 2020-02-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208953)
---
*AI Analytics · CC0 1.0*